Aktiesnakken — December 2011
-
genmab rundede lige 17% op
-
18,26% på GEN
-
ufatteligt.
-
investormøde igår om ASH resultater...
-
jeg tror den stiger på dagens nyheder. Husk den blev traded til cash value, så der er meget priced ind
-
Tror nu også der er nogle investorer der kunne have gavn af at få Arzerra's potentiale skåret ud i pap
-
men der er snart heller ikke mere tilbage at kunne blive skuffet over
-
hvilke 73 alf?
-
-
MS forsøget ?? har Du et link
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind